Journal
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
Volume 49, Issue 6, Pages -Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/03000605211024490
Keywords
Microvascular occlusion; ST elevation myocardial infarction; C-reactive protein; troponin T; syndecan-1; primary percutaneous coronary intervention
Ask authors/readers for more resources
This study aimed to determine predictors of microvascular occlusion in patients with STEMI after pPCI, finding that CRP, TnT, and syndecan-1 levels can be used as serum biomarkers for MVO in these patients. These factors were independently associated with the occurrence of MVO.
Objective This study aimed to determine predictors of microvascular occlusion (MVO) in patients with ST elevation myocardial infarction (STEMI) after primary percutaneous coronary intervention (pPCI). Methods This retrospective, observational study consecutively included 113 patients with STEMI undergoing pPCI. Cardiac magnetic resonance imaging was used to determine the presence of MVO in these patients. Biomarkers in serum were routinely tested 1 day after pPCI. Multivariable logistic regression analysis was used to evaluate significant predictors of occurrence of MVO. Results There were 62 patients in the MVO group and 51 patients in the non-MVO group. C-reactive protein (CRP), thrombomodulin, lymphatic vessel endothelial hyaluronan receptor-1, syndecan-1, and troponin T (TnT) levels after the procedure were significantly higher in the MVO group than in the non-MVO group. CRP (hazard ratio [HR]=1.036), TnT (HR=1.316), and syndecan-1 (HR=1.986) levels were independently associated with MVO in patients with acute myocardial infarction after pPCI. Conclusions Levels of CRP, TnT, and syndecan-1 can be used as serum biomarkers for MVO in patients with STEMI receiving pPCI.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available